166 related articles for article (PubMed ID: 17206924)
1. Oral controlled-release formulation in veterinary medicine.
Lavy E; Steinman A; Soback S
Crit Rev Ther Drug Carrier Syst; 2006; 23(3):165-204. PubMed ID: 17206924
[TBL] [Abstract][Full Text] [Related]
2. Companion animal physiology and dosage form performance.
Sutton SC
Adv Drug Deliv Rev; 2004 Jun; 56(10):1383-98. PubMed ID: 15191788
[TBL] [Abstract][Full Text] [Related]
3. Terminology challenges: defining modified release dosage forms in veterinary medicine.
Martinez MN; Lindquist D; Modric S
J Pharm Sci; 2010 Aug; 99(8):3281-90. PubMed ID: 20213837
[TBL] [Abstract][Full Text] [Related]
4. Scalable Gastric Resident Systems for Veterinary Application.
Hayward A; Bensel T; Mazdiyasni H; Rogner J; Kirtane AR; Lee YL; Hua T; Bajpayee A; Collins J; McDonnell S; Cleveland C; Lopes A; Wahane A; Langer R; Traverso G
Sci Rep; 2018 Aug; 8(1):11816. PubMed ID: 30087406
[TBL] [Abstract][Full Text] [Related]
5. Selection of oral controlled-release drugs: a critical decision for the physician.
Arnold RJ; Kaniecki DJ
South Med J; 1993 Feb; 86(2):208-14. PubMed ID: 8434294
[TBL] [Abstract][Full Text] [Related]
6. Challenges and opportunities in polymer technology applied to veterinary medicine.
Bermudez JM; Cid AG; Ramírez-Rigo MV; Quinteros D; Simonazzi A; Sánchez Bruni S; Palma S
J Vet Pharmacol Ther; 2014 Apr; 37(2):105-24. PubMed ID: 23980692
[TBL] [Abstract][Full Text] [Related]
7. Sustained release veterinary parenteral products.
Medlicott NJ; Waldron NA; Foster TP
Adv Drug Deliv Rev; 2004 Jun; 56(10):1345-65. PubMed ID: 15191786
[TBL] [Abstract][Full Text] [Related]
8. Getting the right drug at the right dosage. Personalized medicine brings precision to drug treatment.
AVMA Group Health and Life Insurance Trust
J Am Vet Med Assoc; 2008 Oct; 233(8):1212-3. PubMed ID: 19180707
[No Abstract] [Full Text] [Related]
9. Drug solubility classification in the bovine.
Martinez MN; Apley MD
J Vet Pharmacol Ther; 2012 Apr; 35 Suppl 1():93-7. PubMed ID: 22413796
[TBL] [Abstract][Full Text] [Related]
10. Novel oral drug formulations. Their potential in modulating adverse effects.
Florence AT; Jani PU
Drug Saf; 1994 Mar; 10(3):233-66. PubMed ID: 8043223
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic and pharmacodynamic aspects of gastroretentive dosage forms.
Hoffman A; Stepensky D; Lavy E; Eyal S; Klausner E; Friedman M
Int J Pharm; 2004 Jun; 277(1-2):141-53. PubMed ID: 15158977
[TBL] [Abstract][Full Text] [Related]
12. Current challenges facing the determination of product bioequivalence in veterinary medicine.
Martinez MN; Hunter RP
J Vet Pharmacol Ther; 2010 Oct; 33(5):418-33. PubMed ID: 20840385
[TBL] [Abstract][Full Text] [Related]
13. Sustained-release injectables formed in situ and their potential use for veterinary products.
Matschke C; Isele U; van Hoogevest P; Fahr A
J Control Release; 2002 Dec; 85(1-3):1-15. PubMed ID: 12480306
[TBL] [Abstract][Full Text] [Related]
14. Pharmaceutical challenges in veterinary product development.
Ahmed I; Kasraian K
Adv Drug Deliv Rev; 2002 Oct; 54(6):871-82. PubMed ID: 12363436
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the Most Frequently Prescribed Extemporaneously Compounded Veterinary Medications at a Large Independent Community Pharmacy.
Karara AH; Hines R; Demir Z; Nnorom B; Horsey R; Twigg G
Int J Pharm Compd; 2016; 20(6):461-467. PubMed ID: 28339384
[TBL] [Abstract][Full Text] [Related]
16. Thoughts on the benefits of personalized medicine.
Greek J; Greek R
J Am Vet Med Assoc; 2009 Jan; 234(1):40. PubMed ID: 19119962
[No Abstract] [Full Text] [Related]
17. Dissolution test development for complex veterinary dosage forms: oral boluses.
Fahmy R; Marnane B; Bensley D; Hollenbeck RG
AAPS PharmSci; 2002; 4(4):E35. PubMed ID: 12646007
[TBL] [Abstract][Full Text] [Related]
18. Drug solubility classification in the dog.
Martinez MN; Papich MG
J Vet Pharmacol Ther; 2012 Apr; 35 Suppl 1():87-91. PubMed ID: 22413795
[TBL] [Abstract][Full Text] [Related]
19. Controlling drug effects through improved oral formulations. The pharmacokinetics of the prazosin gastrointestinal therapeutic system.
DiPiro JT
Am J Med; 1989 Aug; 87(2A):31S-35S. PubMed ID: 2764016
[TBL] [Abstract][Full Text] [Related]
20. Development of antiparasitic drugs in the 21st century.
Geary TG; Thompson DP
Vet Parasitol; 2003 Jul; 115(2):167-84. PubMed ID: 12878421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
